Does inhaled corticosteroid use affect the risk of ?COVID-19-related death?

Alexander Jordan, Pradeesh Sivapalan, Jens-Ulrik Jensen

Source: Breathe, 17 (1) 200275; 10.1183/20734735.0275-2020

Journal Issue: March

Disease area: Airway diseases

Abstract

This reduced incidence is conflicting with the fact that patients with COPD have worse outcomes when infected, as measured on the risk of hospitalisation, severity and mortality [6–8]. The same is true for asthma patients, but the effect size seems smaller [7, 9].

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Alexander Jordan, Pradeesh Sivapalan, Jens-Ulrik Jensen. Does inhaled corticosteroid use affect the risk of ?COVID-19-related death?. Breathe, 17 (1) 200275; 10.1183/20734735.0275-2020

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Inhaled beta2-agonists and death for asthma: can we overcome this risk? Source: Annual Congress 2007 - Effect of long acting beta-agonists on severe asthma exacerbations and asthma-related deaths Year: 2007
Is there a problem with inhaled corticosteroid use in COPD? Source: Virtual Congress 2020 – Airway diseases Year: 2020
Is there a problem with oral corticosteroid use in asthma? Source: Virtual Congress 2020 – Airway diseases Year: 2020
Are COPD patients with pneumonia who are taking inhaled corticosteroids at higher risk of dying? Source: Eur Respir J 2011; 37: 1-3 Year: 2011
Is GLCCI1 associated with response to inhaled corticosteroids in asthma patients? Source: Annual Congress 2012 - Gene-environment treatment and asthma Year: 2012
How can we minimise the use of regular oral corticosteroids in asthma? Source: Eur Respir Rev, 29 (155) 190085; 10.1183/16000617.0085-2019 Year: 2020
Inhaled corticosteroids preventing pneumonia mortality: paradox or selection bias? Source: Eur Respir J, 53 (2) 1802112; 10.1183/13993003.02112-2018 Year: 2019
Does combination therapy lead to better adherence in asthma? Source: Annual Congress 2010 - Combination therapy in asthma and COPD Year: 2010
Regular use of inhaled corticosteroids and the long-term prevention of hospitalisation for asthma Source: Eur Respir J 2002; 20: Suppl. 38, 8s Year: 2002
Inhaled corticosteroids reduce growth. Or do they? Source: Eur Respir J 2001; 17: 287-294 Year: 2001
Does adherence to inhaled corticosteroids predict asthma-related outcomes over time? A cohort study Source: Eur Respir J, 54 (6) 1900901; 10.1183/13993003.00901-2019 Year: 2019
Does the treatment with inhaled steroids or long acting β-2-agonists prevent LRTIs? Source: Annual Congress 2009 - PG1 EU GRACE Network Full-day Course: vaccination and preventive measures for LRTIs in the community: what’s new? Year: 2009
Mild asthma. Is constant therapy by inhaled steroids necessary? Source: Eur Respir J 2006; 28: Suppl. 50, 500s Year: 2006
Suppression of F_ENO with observed inhaled corticosteroid therapy in severe asthma: is it a useful test in clinical practice? Source: ERJ Open Res, 5 (4) 00123-2019; 10.1183/23120541.00123-2019 Year: 2019
Inhaled corticosteroid therapy reduces the risk of rehospitalization and all-cause mortality in elderly asthmatics Source: Eur Respir J 2001; 17: 380-385 Year: 2001
Is beta-agonist alone prescribed in case of uncontrolled asthma? Source: Annual Congress 2008 - Asthma: growing understanding of influential factors Year: 2008
The risk of mycobacterial infections associated with inhaled corticosteroid use Source: Eur Respir J, 50 (3) 1700037; 10.1183/13993003.00037-2017 Year: 2017
Does the use of inhaled corticosteroids in asthma benefit lung function in the long-term? A systematic review and meta-analysis Source: Eur Respir Rev, 30 (159) 200185; 10.1183/16000617.0185-2020 Year: 2021